Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: A randomised, multicentre, parallel-group, open study

Human Psychopharmacology

Volumn 22, Issue 5, 2007, Pages 299-306

  Boidi, Giuseppina ^a   Ferro, Maurizio ^a  

^a SPDC Dipartimento di Salute Mentale ASL 3   (Italy)

Author keywords

Atypical antipsychotics; Dose initiation; Quetiapine; Schizoaffective disorder; Schizophrenia; Tolerability

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; QUETIAPINE;

ADULT; AGED; AGITATION; ARTICLE; BLOOD PRESSURE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DROP ATTACK; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HOSPITAL PATIENT; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OPEN STUDY; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; TREATMENT OUTCOME; WEIGHT GAIN;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 34547517811     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.844     Document Type: Article

References (28)

1. American Psychiatric Association. 2004. Practice guideline for the treatment of patients with schizophrenia. Available at www.psych.org (accessed 15 August 2005).
2. Arango C, Bobes J. 2004. Managing acute exacerbations of schizophrenia: focus on quetiapine. Curr Med Res Opin 20: 619-626.
3. Arvanitis LA, Miller BG, The Seroquel Trial 13 study group. 1997. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Bowl Psychiatry 42: 233-246.
4. AstraZeneca. 2005. Seroquel® (quetiapine fumarate) tablets/US prescribing information. Available at http://www.astrazeneca-us.com/pi/ Seroquel.pdf (accessed 1 June 2006).
5. Battaglia J. 2005. Pharmacologieal management of acute agitation. Drugs 65: 1207-1222.
6. Bobes J, Garcia-Portilla MP, Saiz PA, et al. 2002. High degree of tolerability for monotherapy with high doses of quetiapine: a case report. J Clin Psychiatry 63: 1048-1049.
7. Borison RL, Arvanitis LA, Miller BG, The US Seroquel study group. 1996. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. J Clin Psychopharmacol 16: 158-169.
8. Buckley PF. 2004. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Curr Med Res Opin 20: 1357-1363.
9. Chengappa KNR, Goldstein JM, Greenwood M, John V, Levine J. 2003. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Clin Ther 25: 530-541.
10. Citrome L, Jaffe A, Levine J. 2007. Datapoints: the ups and downs of dosing second-generation antipsychotics. Psychiatr Serv 58:11.
11. Citrome L, Jaffe A, Levine J, et al. 2005. Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies. J Clin Psychiatry 66: 1512-1516.
12. Copolov DL, Link CGG, Kowalcyk B. 2000. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Psychol Med 30: 95-105.
13. Currier GW. 2000. Atypical antipsychotic medications in the psychiatric emergency service. J Clin Psychiatry 61(Suppl. 14): 21-26.
14. Currier GW, Medori R. 2006. Orally versus intramuscularly administered antipsychotic drugs in psychiatric emergencies. J Psychiatr Pract 12: 30-40.
15. Cutler AJ, Goldstein JM, Tumas JA. 2002. Dosing and switching strategies for quetiapine fumarate. Clin Ther 24: 209-222.
16. Ganesan S, Levy M, Bilsker D, Khanbhai I. 2005. Effectiveness of quetiapine for the management of aggressive psychosis in the emergency psychiatric setting: a naturalistic uncontrolled trial, Int J Psychiatry Clin Pract 9: 199-203.
17. Keks N, Tonso M, Tabone K, et al. 2006. Clinical experience with atypical antipsychotics in an acute inpatient unit: focus on quetiapine, Int J Psychiatry Clin Pract 10: 138-141.
18. King DJ, Link CGG, Kowalcyk B. 1998. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia. Psychopharmacology (Berl) 137: 139-146.
19. Kinon BJ, Ahl J, Rotelli MD, McMullen E. 2004a. Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia. Am J Emerg Med 22: 181-186.
20. Kinon BJ, Ahl J, Stauffer VL, Hill AL, Buckley PF. 2004b. Dose response and atypical antipsychotics in schizophrenia. CNS Drugs 18: 597-616.
21. McEvoy JP, Scheifler PL, Frances A. 1999. Expert consensus guideline series. Treatment of schizophrenia 1999. J Clin Psychiatry 60(Suppl. 11): 8-80.
22. Meats P. 1997. Quetiapine ('Seroquel'); an effective and well-tolerated atypical antipsychotic, Int J Psychiatry Clin Pract 1: 231-239.
23. Pae CU, Kim TS, Kim JJ, et al. 2005. Rapid versus conventional titration of quetiapine la acute schizophrenia. Eur Neuropsychopharmacol 15: S505.
24. Pajonk FG, Schwertner AK, Seelig MA. 2006. Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series. J Psychopharmacol 20: 119-124.
25. Peuskens J, Link CGG, 1997. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand 96: 265-273.
26. Small JG, Hirsch SR, Arvanitis LA, et al. 1997. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry 54: 549-557.
27. Smith MA, McCoy R, Hamer-Maansson J, Brecher M. 2005. Rapid dose escalation with quetiapine: a pilot study. J Clin Psychopharmacol 25: 331-335.
28. Tandon R, Jibson MD. 2005. Comparing efficacy of first-line atypical antipsychotics: no evidence of differential efficacy between risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole, Int J Psychiatry Clin Pract 9: 204-212.